Chest Medicine (all articles)
[Abstract Only] Randomized trial: Effect of sustained-release morphine for refractory breathlessness in COPD
18 Aug, 2020 | 07:25h | UTC
Commentary on Twitter
Sustained-Release Morphine improves quality of life in patients with #COPD and refractory #breathlessness https://t.co/whXcWPlKiv via @JAMAInternalMed part of @JAMANetwork #pallipulm
— Daisy Janssen (@DJAJanssen) August 17, 2020
ATS Guideline: Long-term noninvasive ventilation in chronic stable hypercapnic COPD
18 Aug, 2020 | 07:23h | UTCNews Release: New practice guidelines on non-invasive ventilation in chronic stable Hypercapnic COPD – American Thoracic Society
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
16 Aug, 2020 | 22:36h | UTCRobust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 – Cell
Commentary on Twitter
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 https://t.co/7gnaFW0nyf SARS-CoV-2 elicits robust, broad and highly functional memory T cell responses,
— Carl Heneghan (@carlheneghan) August 15, 2020
Scientists find the likely order of COVID-19 symptoms
16 Aug, 2020 | 22:32h | UTCUSC scientists find the likely order of COVID-19 symptoms – University of Southern California
Original Study: Modeling the Onset of Symptoms of COVID-19 – Frontiers in Public Health
Commentary on Twitter
Medical scientists in California identify the order in which #COVID19's symptoms occur: fever, cough, muscle pain, & then nausea, and/or vomiting & diarrhea. Knowing the order may help patients seek care promptly or decide sooner to self-isolate https://t.co/7FoCNLUlbR pic.twitter.com/QVNI1VcN3f
— delthia ricks ? (@DelthiaRicks) August 16, 2020
Emerging pandemic diseases: How we got to COVID-19
16 Aug, 2020 | 22:34h | UTCEmerging Pandemic Diseases: How We Got To COVID-19 – Cell
Commentary on Twitter
Must read @CellCellPress: #AnthonyFauci & David Morens on Emerging #Pandemic #Diseases: How We Got To #COVID19 https://t.co/PuwC4L7d24 #SARSCoV2 #infection @NIAIDNews #virus #tonyfauci pic.twitter.com/mJF7Vs7De1
— Sri Baqri (Narasimhan) (@Sri_Baqri) August 15, 2020
Study suggests low risk of post-discharge venous thromboembolism following hospital admission with COVID-19
16 Aug, 2020 | 22:24h | UTCPost-discharge venous thromboembolism following hospital admission with COVID-19 – Blood
Commentary: Post-Hospital Venous Thromboembolism in Patients With COVID-19 – American College of Cardiology
Clinical update: Influenza in the COVID-19 era
16 Aug, 2020 | 22:31h | UTCInfluenza in the COVID-19 Era – JAMA
Commentary on Twitter
Despite the rapid pace of progress in the areas of #SARSCoV2 diagnostics, treatment, and vaccine development, the population remains vulnerable to concurrent influenza and #COVID19 epidemics https://t.co/414veJwuYj
— JAMA (@JAMA_current) August 14, 2020
Cohort study: ECMO for severe acute respiratory distress syndrome associated with COVID-19
16 Aug, 2020 | 22:28h | UTCInvited Commentary: ECMO for severe ARDS associated with COVID-19: now we know we can, but should we? – The Lancet Respiratory Medicine
Commentary on Twitter
Our approaches and treatments for severe #COVID19 keep getting better. Use of blood thinners, dexamethasone, when to use mechanical ventilation, etc. We're also getting smarter about the use of ECMO@LancetRespirMed https://t.co/LXfZnVaEJ8@JAMASurgery https://t.co/Osmjne9btb pic.twitter.com/Pq1u6TMNV8
— Eric Topol (@EricTopol) August 14, 2020
Diagnosing COVID‐19 in the ED: A scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases
16 Aug, 2020 | 22:23h | UTC
Randomized trial: Methylprednisolone as adjunctive therapy for patients hospitalized with COVID-19
14 Aug, 2020 | 01:53h | UTCRelated Study: Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report – New England Journal of Medicine
Commentary on Twitter
Metcovid Double Blind PH. 2
RCT ??~ 400 pts #CID
Methylprednisolon 0.5mg/kg twice daily x5d #COVID19 Hospitalized pts #COVID19 did not reduce 28d mortality V placebo
Is it Right Drug, Dose, Duration
High dose vs RECOVERY
DEX less mineralocorticoid
5 v 10 https://t.co/EBIRWYouSQ pic.twitter.com/OzGJkqjkrJ— Antibiotic Steward? Bassam Ghanem (@ABsteward) August 13, 2020
Coagulopathy in COVID-19: Manifestations and management
14 Aug, 2020 | 01:21h | UTCCoagulopathy in COVID-19: Manifestations and management – Cleveland Clinic Journal of Medicine
[Preprint] Observational study: Effect of convalescent plasma on mortality among hospitalized patients with COVID-19
14 Aug, 2020 | 01:24h | UTCCommentary: Large study suggests convalescent plasma can help treat Covid-19, but experts have doubts – STAT
Commentary on Twitter
? Preliminary results from convalescent plasma Expanded Access Program ?
35,322 patients ?
Not an RCT ?
But, lower mortality with earlier administration & higher antibody titre support possible efficacy ?https://t.co/xwzz3mQ0qX pic.twitter.com/Utquky4wW1
— Ilan Schwartz MD PhD (@GermHunterMD) August 13, 2020
Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19
14 Aug, 2020 | 01:17h | UTCCommentary: New prediction model can forecast personalized risk for COVID-19-related hospitalization – MedicalXpress
Online risk calculator: Predict Hospitalization Risk for COVID-19 Positive
Study: Household contact is the primary setting for transmission of SARS-CoV-2
14 Aug, 2020 | 01:22h | UTC
Randomized trial: AVIFAVIR for Treatment of Patients with Moderate COVID-19
13 Aug, 2020 | 00:28h | UTC
Commentary on Twitter
NEW ?? #CID @IDSAInfo
AVIFAVIR(favipiravir) for Treatment of Patients with Moderate #COVID19 : Interim Results of a Phase II/III Multicenter Randomized Clinical Trial #IDTwitter https://t.co/PwUcCWu5KQ pic.twitter.com/6N6lxHUu9K— Antibiotic Steward? Bassam Ghanem (@ABsteward) August 8, 2020
ECMO for patients with COVID-19 in severe respiratory failure
13 Aug, 2020 | 00:23h | UTC
Meta-analysis: Laboratory features of severe vs. non-severe COVID-19 patients
13 Aug, 2020 | 00:26h | UTC
Association between youth smoking, electronic cigarette use, and Coronavirus Disease 2019
13 Aug, 2020 | 00:16h | UTCCommentary: Vaping linked to COVID-19 risk in teens and young adults, study finds – Stanford Medicine
[Preprint] Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients
13 Aug, 2020 | 00:18h | UTCViable SARS-CoV-2 in the air of a hospital room with COVID-19 patients – medRxiv
Commentaries: Viable SARS-CoV-2 aerosols detected in a hospital room with COVID-19 patients – News Medical AND ‘A Smoking Gun’: Infectious Coronavirus Retrieved From Hospital Air – The New York Times
Diagnostic performance of Chest CT for SARS-CoV-2 infection in individuals with or without COVID-19 symptoms
13 Aug, 2020 | 00:22h | UTC
Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder
13 Aug, 2020 | 00:14h | UTC
Podcast: Updated pulmonary embolism guidelines
12 Aug, 2020 | 23:57h | UTCUpdated Pulmonary Embolism Guidelines – JAMA
Opinion: Track COVID-19 sickness, not just positive tests and deaths
12 Aug, 2020 | 02:40h | UTCTrack COVID-19 sickness, not just positive tests and deaths – Nature
Management of post-acute Covid-19 in primary care
12 Aug, 2020 | 02:42h | UTCManagement of post-acute covid-19 in primary care – The BMJ
Commentary: We Need to Take Care of the Growing Number of Long-term COVID-19 Patients – TIME
NEW #BMJInfographic summarises the assessment and initial management of patients with continuing symptoms from #COVID19 #LongCovid https://t.co/MOjVNNcjkw @will_s_t pic.twitter.com/tln3Hw6QkJ
— The BMJ (@bmj_latest) August 11, 2020
Filtration efficiency of hospital face mask alternatives available for use during the Covid-19 pandemic
12 Aug, 2020 | 02:36h | UTCEditorial: Filtration Efficiency, Effectiveness, and Availability of N95 Face Masks for COVID-19 Prevention
Commentary: Sanitized N95s acceptable alternatives to new masks, JAMA study finds – Healthcare Dive